{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:24:47Z","timestamp":1787509487740,"version":"build-2736575974"},"reference-count":55,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The interaction between LC and active TB has been known for many years. The first description of \u2018cancerous phthisis\u2019 was reported by Bayle in 1810. The results of subsequent attempts to establish an etiological correlation between the two clinical entities have ranged from insignificant\u2014even antagonistic\u2014to a direct causal relationship. This narrative review explores the relationship between tuberculosis and LC assessing overall and site-specific malignancy risks in individuals with TB compared with the general population. We also examine the timing of cancer development following TB, highlighting periods of elevated risk. Chronic inflammation, immune dysregulation, and metabolic changes associated with TB may contribute to tumor initiation and progression, with organ-specific factors influencing susceptibility to cancers such as lung, head and neck, gastrointestinal, and hematologic malignancies. Clinically, awareness of these interactions supports targeted TB screening in high-risk cancer patients, careful monitoring for TB reactivation during cancer therapy, and consideration of immunological and metabolic factors when planning treatment.<\/jats:p>","DOI":"10.3390\/cancers18010083","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T07:52:59Z","timestamp":1766994779000},"page":"83","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tuberculosis and Lung Cancer: Insights from a Narrative Review"],"prefix":"10.3390","volume":"18","author":[{"given":"Antonio-Andrei","family":"Cotea","sequence":"first","affiliation":[{"name":"Department of Cardio-Thoracic Pathology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"National Institute of Pneumophthisiology \u201cMarius Nasta\u201d, 050159 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6742-6334","authenticated-orcid":false,"given":"Ancuta-Alina","family":"Constantin","sequence":"additional","affiliation":[{"name":"Department of Cardio-Thoracic Pathology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"National Institute of Pneumophthisiology \u201cMarius Nasta\u201d, 050159 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin-Dumitru","family":"Mihaltan","sequence":"additional","affiliation":[{"name":"Department of Cardio-Thoracic Pathology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"National Institute of Pneumophthisiology \u201cMarius Nasta\u201d, 050159 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Cancer risk in tuberculosis patients in a high endemic area","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1080\/15257770.2024.2308522","article-title":"Tuberculosis and lung cancer: Metabolic pathways play a key role","volume":"43","author":"Ferdosnejad","year":"2024","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Luczynski, P., Poulin, P., Romanowski, K., and Johnston, J.C. (2022). Tuberculosis and risk of cancer: A systematic review and meta-analysis. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0278661"},{"key":"ref_4","first-page":"e70213","article-title":"Coexisting Lung Cancer and Pulmonary Tuberculosis: A Comprehensive Review From Incidence to Management","volume":"8","author":"Zhou","year":"2025","journal-title":"Cancer Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.lungcan.2018.05.030","article-title":"Management of co-existent tuberculosis and lung cancer","volume":"122","author":"Ho","year":"2018","journal-title":"Lung Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jtho.2021.03.030","article-title":"Burden of Tracheal, Bronchus, and Lung Cancer and Its Attributable Risk Factors in 204 Countries and Territories, 1990 to 2019","volume":"16","author":"Safiri","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/epidemiologia5040053","article-title":"Global, Regional, and National Burden of Tracheal, Bronchus, and Lung Cancer in 2022: Evidence from the GLOBOCAN Study","volume":"5","author":"Sharma","year":"2024","journal-title":"Epidemiologia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S1470-2045(11)70105-X","article-title":"Tuberculosis and cancer: A complex and dangerous liaison","volume":"12","author":"Vento","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijc.27477","article-title":"What proportion of lung cancer in never-smokers can be attributed to known risk factors?","volume":"131","author":"Sisti","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hwang, S.Y., Kim, J.Y., Lee, H.S., Lee, S., Kim, D., Kim, S., Hyun, J.H., Shin, J.I., Lee, K.H., and Han, S.H. (2022). Pulmonary Tuberculosis and Risk of Lung Cancer: A Systematic Review and Meta-Analysis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030765"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41533-025-00417-x","article-title":"The interactions among factors associated with the risk of lung cancer among diabetes patients: A survival tree analysis","volume":"35","author":"Yau","year":"2025","journal-title":"npj Prim. Care Respir. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"220025","DOI":"10.1183\/16000617.0025-2022","article-title":"Lung cancer occurrence after an episode of tuberculosis: A systematic review and meta-analysis","volume":"31","author":"Cuba","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1702819","DOI":"10.1155\/2022\/1702819","article-title":"Incidence and Risk of Lung Cancer in Tuberculosis Patients, and Vice Versa: A Literature Review of the Last Decade","volume":"2022","author":"Bhowmik","year":"2022","journal-title":"BioMed Res. Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1513\/AnnalsATS.202010-1240OC","article-title":"Pulmonary Tuberculosis and the Incidence of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease","volume":"19","author":"Park","year":"2022","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Mata-Mar\u00edn, J.A., Apaez-Iglesias, M., Cano-D\u00edaz, A.L., S\u00e1nchez-Navarro, J.P., Fern\u00e1ndez-Madinaveitia, D.E., Barriga-Angulo, G., Triana-Gonz\u00e1lez, S., Chaparro-S\u00e1nchez, A., Pompa-Mera, E.N., and Gayt\u00e1n-Mart\u00ednez, J.E. (2025). Prevalence and Risk Factors of Latent Tuberculosis Infection Detected by IGRA in Patients with Immune-Mediated Inflammatory Diseases Before and During Biologic DMARD Therapy (TITAN Study). J. Clin. Med., 14.","DOI":"10.3390\/jcm14144990"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e037827","DOI":"10.1136\/bmjopen-2020-037827","article-title":"Risk of active tuberculosis in migrants diagnosed with cancer: A retrospective cohort study in British Columbia, Canada","volume":"11","author":"Kumar","year":"2021","journal-title":"BMJ Open"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.31557\/APJCP.2020.21.9.2715","article-title":"Incidence of and Risk Factors for Tuberculosis among Cancer Patients in Endemic Area: A Regional Cohort Study","volume":"21","author":"Nanthanangkul","year":"2020","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Huang, J.-Y., Jian, Z.-H., Nfor, O.N., Jhang, K.-M., Ku, W.-Y., Ko, P.-C., Jan, S.-R., Ho, C.-C., Lung, C.-C., and Pan, H.-H. (2015). The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0133367"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.lungcan.2014.07.001","article-title":"Latent TB infection in newly diagnosed lung cancer patients \u2013 A multicenter prospective observational study","volume":"85","author":"Fan","year":"2014","journal-title":"Lung Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4143\/crt.2022.1305","article-title":"The Incidence and Risk Factors of Chronic Pulmonary Infection after Radiotherapy in Patients with Lung Cancer","volume":"55","author":"Choi","year":"2023","journal-title":"Cancer Res. Treat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12885-025-13743-7","article-title":"Incidence and risk factors of serious infections occurred in patients with lung cancer following immune checkpoint blockade therapy","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Bickett, T.E., and Karam, S.D. (2020). Tuberculosis\u2013Cancer Parallels in Immune Response Regulation. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176136"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Vu, A., Glassman, I., Campbell, G., Yeganyan, S., Nguyen, J., Shin, A., and Venketaraman, V. (2024). Host Cell Death and Modulation of Immune Response against Mycobacterium tuberculosis Infection. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25116255"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"115211","DOI":"10.1016\/j.intimp.2025.115211","article-title":"Targeting alveolar macrophages in tuberculosis: Exploiting trained immunity for novel therapeutic approaches","volume":"163","author":"Fang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e2400119","DOI":"10.1002\/adbi.202400119","article-title":"The Biological Role of Macrophage in Lung and Its Implications in Lung Cancer Immunotherapy","volume":"8","author":"Wang","year":"2024","journal-title":"Adv. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"107881","DOI":"10.1016\/j.isci.2023.107881","article-title":"Immunotherapy and biomarkers in patients with lung cancer with tuberculosis: Recent advances and future Directions","volume":"26","author":"Yang","year":"2023","journal-title":"iScience"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"119810","DOI":"10.1016\/j.cca.2024.119810","article-title":"Circular RNAs in tuberculosis and lung cancer","volume":"561","author":"Jabeen","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Hong, M., Huang, X., Zhu, H., Ma, J., and Li, F. (2025). The role of circular RNA in immune response to tuberculosis and its potential as a biomarker and therapeutic target. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1542686"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12935-022-02793-7","article-title":"Exosomal circular RNA: A signature for lung cancer progression","volume":"22","author":"Hussen","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41419-023-05647-w","article-title":"Regulation of the tumor immune microenvironment by cancer-derived circular RNAs","volume":"14","author":"Guan","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.ijbiomac.2022.11.235","article-title":"Circular RNAs and tuberculosis infection","volume":"226","author":"Hemati","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e2352","DOI":"10.1097\/MD.0000000000002352","article-title":"Latent Tuberculosis Infection and the Risk of Subsequent Cancer","volume":"95","author":"Su","year":"2016","journal-title":"Medicine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12885-020-06891-5","article-title":"Cancer incidence attributable to tuberculosis in 2015: Global, regional, and national estimates","volume":"20","author":"Leung","year":"2020","journal-title":"BMC Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/cid\/ciw838","article-title":"Risk of Active Tuberculosis in Patients with Cancer: A Systematic Review and Meta-Analysis","volume":"64","author":"Cheng","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/0218492320984881","article-title":"Screening of latent TB infection in patients with recently diagnosed bronchogenic carcinoma","volume":"29","author":"Abdelwahab","year":"2020","journal-title":"Asian Cardiovasc. Thorac. Ann."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Mortezazadeh, M., Karimi, M., Esfandbod, M., Mofidi, A., Hemmati, N., Kashani, M., Shirsalimi, N., Mahmoudi, S.T.S., and Yazdi, E.K. (2024). Investigation of the prevalence of latent tuberculosis in cancer patients compared to non-cancer patients: A case-control study. Oncol. Rev., 18.","DOI":"10.3389\/or.2024.1445678"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"170077","DOI":"10.1183\/16000617.0077-2017","article-title":"Tuberculosis and lung damage: From epidemiology to pathophysiology","volume":"27","author":"Ravimohan","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1186\/s12885-019-6274-0","article-title":"Primary solid lung cancerous nodules with different sizes: Computed tomography features and their variations","volume":"19","author":"Chu","year":"2019","journal-title":"BMC Cancer"},{"key":"ref_39","first-page":"4454","article-title":"Differentiating mass-like tuberculosis from lung cancer based on radiomics and CT features","volume":"10","author":"Wei","year":"2021","journal-title":"Cancer Res."},{"key":"ref_40","first-page":"45","article-title":"Tuberculosis mimicking lung cancer","volume":"16","author":"Hammen","year":"2015","journal-title":"Respir. Med. Case Rep."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Goyal, A. (2023). Every Hot Spot is not Cancer\u2014Pulmonary Tuberculosis Mimicking Lung Cancer in PET-CT. Int. J. Clin. Stud. Med Case Rep., 25.","DOI":"10.46998\/IJCMCR.2023.25.000603"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.3892\/etm.2017.4737","article-title":"Asymptomatic pulmonary tuberculosis mimicking lung cancer on imaging: A retrospective study","volume":"14","author":"Lang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_43","first-page":"7","article-title":"A Comprehensive Study on the Correlation of Treatment, Diagnosis and Epidemiology of Tuberculosis and Lung Cancer","volume":"22","author":"Sheikhpour","year":"2023","journal-title":"Tanaffos"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jiac.2021.10.017","article-title":"Tuberculosis during lung cancer treatment-A case series","volume":"28","author":"Tamura","year":"2022","journal-title":"J. Infect. Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/IDR.S497006","article-title":"Simultaneous Anti-Tuberculosis and Anti-Tumor Treatment with Immune Checkpoint Inhibitors for Co-Existent Pulmonary Tuberculosis and Advanced Lung Cancer","volume":"18","author":"Wang","year":"2025","journal-title":"Infect. Drug Resist."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Fang, C., He, X., Tang, F., Wang, Z., Pan, C., Zhang, Q., Wu, J., Wang, Q., Liu, D., and Zhang, Y. (2025). Where lung cancer and tuberculosis intersect: Recent advances. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1561719"},{"key":"ref_47","unstructured":"(2022). Mini Review: Reactivation of Tuberculosis in Patients with Solid Cancer. Cancer Ther. Oncol. Int. J., 21, 01\u201303."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2102512","DOI":"10.1183\/13993003.02512-2021","article-title":"The paradox of immune checkpoint inhibition re-activating tuberculosis","volume":"60","author":"Ahmed","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1093\/oncolo\/oyad340","article-title":"Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy","volume":"29","author":"Chen","year":"2024","journal-title":"Oncologist"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s40425-019-0717-7","article-title":"Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: Current evidence and clinical practice recommendations","volume":"7","author":"Anastasopoulou","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Lin, C., Xu, G., Gao, S., Feng, T., and Li, S. (2023). Tuberculosis infection following immune checkpoint inhibitor treatment for advanced cancer: A case report and literature review. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1162190"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00002018-200225020-00005","article-title":"Clinically Significant Interactions with Drugs Used in the Treatment of Tuberculosis","volume":"25","author":"Yew","year":"2002","journal-title":"Drug Saf."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Lee, H.-S., Wei, Y.-F., and Shu, C.-C. (2023). Influence of Rifamycin on Survival in Patients with Concomitant Lung Cancer and Pulmonary Tuberculosis. Biomedicines, 11.","DOI":"10.3390\/biomedicines11123130"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-0711-5-3","article-title":"Roles of rifampicin in drug-drug interactions: Underlying molecular mechanisms involving the nuclear pregnane X receptor","volume":"5","author":"Chen","year":"2006","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40268-016-0133-0","article-title":"Pharmacokinetic Interaction of Rifampicin with Oral Versus Intravenous Anticancer Drugs: Challenges, Dilemmas and Paradoxical Effects Due to Multiple Mechanisms","volume":"16","author":"Srinivas","year":"2016","journal-title":"Drugs R&D"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/1\/83\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T07:59:58Z","timestamp":1766995198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/1\/83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["cancers18010083"],"URL":"https:\/\/doi.org\/10.3390\/cancers18010083","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]}}}